Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
1996 1
2001 2
2002 1
2003 1
2004 1
2005 2
2006 3
2007 1
2008 4
2009 3
2010 2
2012 5
2013 7
2014 5
2015 3
2016 7
2017 8
2018 6
2019 7
2020 9
2021 9
2022 3
Text availability
Article attribute
Article type
Publication date

Search Results

79 results
Results by year
Filters applied: . Clear all
Page 1
EANO guidelines for the diagnosis and treatment of meningiomas.
Goldbrunner R, Minniti G, Preusser M, Jenkinson MD, Sallabanda K, Houdart E, von Deimling A, Stavrinou P, Lefranc F, Lund-Johansen M, Moyal EC, Brandsma D, Henriksson R, Soffietti R, Weller M. Goldbrunner R, et al. Among authors: brandsma d. Lancet Oncol. 2016 Sep;17(9):e383-91. doi: 10.1016/S1470-2045(16)30321-7. Epub 2016 Aug 30. Lancet Oncol. 2016. PMID: 27599143 Free article. Review.
Primary CNS lymphoma in HIV infection.
Brandsma D, Bromberg JEC. Brandsma D, et al. Handb Clin Neurol. 2018;152:177-186. doi: 10.1016/B978-0-444-63849-6.00014-1. Handb Clin Neurol. 2018. PMID: 29604975 Review.
Leptomeningeal metastases: a RANO proposal for response criteria.
Chamberlain M, Junck L, Brandsma D, Soffietti R, Rudà R, Raizer J, Boogerd W, Taillibert S, Groves MD, Le Rhun E, Walker J, van den Bent M, Wen PY, Jaeckle KA. Chamberlain M, et al. Among authors: brandsma d. Neuro Oncol. 2017 Apr 1;19(4):484-492. doi: 10.1093/neuonc/now183. Neuro Oncol. 2017. PMID: 28039364 Free PMC article. Review.
EANO-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up of patients with leptomeningeal metastasis from solid tumours.
Le Rhun E, Weller M, Brandsma D, Van den Bent M, de Azambuja E, Henriksson R, Boulanger T, Peters S, Watts C, Wick W, Wesseling P, Rudà R, Preusser M; EANO Executive Board and ESMO Guidelines Committee. Le Rhun E, et al. Among authors: brandsma d. Ann Oncol. 2017 Jul 1;28(suppl_4):iv84-iv99. doi: 10.1093/annonc/mdx221. Ann Oncol. 2017. PMID: 28881917 Free article. No abstract available.
Prognostic factors in leptomeningeal metastases.
Le Rhun E, Devos P, Weller J, Seystahl K, Mo F, Compter A, Berghoff AS, Jongen JLM, Wolpert F, Rudà R, Brandsma D, van den Bent M, Preusser M, Herrlinger U, Weller M. Le Rhun E, et al. Among authors: brandsma d. Neuro Oncol. 2021 Jul 1;23(7):1208-1209. doi: 10.1093/neuonc/noab051. Neuro Oncol. 2021. PMID: 33830220 Free PMC article. No abstract available.
Single-agent bevacizumab or lomustine versus a combination of bevacizumab plus lomustine in patients with recurrent glioblastoma (BELOB trial): a randomised controlled phase 2 trial.
Taal W, Oosterkamp HM, Walenkamp AM, Dubbink HJ, Beerepoot LV, Hanse MC, Buter J, Honkoop AH, Boerman D, de Vos FY, Dinjens WN, Enting RH, Taphoorn MJ, van den Berkmortel FW, Jansen RL, Brandsma D, Bromberg JE, van Heuvel I, Vernhout RM, van der Holt B, van den Bent MJ. Taal W, et al. Among authors: brandsma d. Lancet Oncol. 2014 Aug;15(9):943-53. doi: 10.1016/S1470-2045(14)70314-6. Epub 2014 Jul 15. Lancet Oncol. 2014. PMID: 25035291 Clinical Trial.
Guard cells control hypocotyl elongation through HXK1, HY5, and PIF4.
Kelly G, Brandsma D, Egbaria A, Stein O, Doron-Faigenboim A, Lugassi N, Belausov E, Zemach H, Shaya F, Carmi N, Sade N, Granot D. Kelly G, et al. Among authors: brandsma d. Commun Biol. 2021 Jun 21;4(1):765. doi: 10.1038/s42003-021-02283-y. Commun Biol. 2021. PMID: 34155329 Free PMC article.
79 results